Drug Shortage Report for CEFAZOLIN FOR INJECTION, USP
| Report ID | 105871 |
| Drug Identification Number | 02401029 |
| Brand name | CEFAZOLIN FOR INJECTION, USP |
| Common or Proper name | Cefazolin for Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFAZOLIN |
| Strength(s) | 100G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100g SmartPak |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-13 |
| Estimated end date | 2021-03-22 |
| Actual end date | 2021-03-22 |
| Shortage status | Resolved |
| Updated date | 2021-03-23 |
| Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that the following products have been removed from allocation as of today, Monday, March 22, 2021. The products will be available to all customers through all distribution channels without any volume restrictions. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2021-03-23 | English | Compare |
| v14 | 2021-03-22 | French | Compare |
| v13 | 2021-03-22 | English | Compare |
| v12 | 2021-03-22 | French | Compare |
| v11 | 2021-03-22 | English | Compare |
| v10 | 2020-10-02 | French | Compare |
| v9 | 2020-10-02 | English | Compare |
| v8 | 2020-07-08 | French | Compare |
| v7 | 2020-07-08 | English | Compare |
| v6 | 2020-07-08 | English | Compare |
| v5 | 2020-07-08 | English | Compare |
| v4 | 2020-02-13 | French | Compare |
| v3 | 2020-02-13 | English | Compare |
| v2 | 2020-02-12 | French | Compare |
| v1 | 2020-02-12 | English | Compare |
Showing 1 to 15 of 15